Literature DB >> 18333859

A natural approach to treatment of inflammatory bowel disease.

Mario Guslandi1.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18333859      PMCID： PMC2291363          DOI： 10.1111/j.1365-2125.2008.03147.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease.

Authors:  Athos Bousvaros; Stefano Guandalini; Robert N Baldassano; Christine Botelho; Jonathan Evans; George D Ferry; Barry Goldin; Lori Hartigan; Subra Kugathasan; Joseph Levy; Karen F Murray; Maria Oliva-Hemker; Joel R Rosh; Vasundhara Tolia; Anna Zholudev; Jon A Vanderhoof; Patricia L Hibberd
Journal:  Inflamm Bowel Dis       Date:  2005-09       Impact factor: 5.325

Review 2.  Antibiotics for inflammatory bowel disease: do they work?

Authors:  Mario Guslandi
Journal:  Eur J Gastroenterol Hepatol       Date:  2005-02       Impact factor: 2.566

3.  Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection.

Authors:  Andre Van Gossum; Olivier Dewit; Edouard Louis; Geert de Hertogh; Filip Baert; Fernand Fontaine; Martine DeVos; Marc Enslen; Marc Paintin; Denis Franchimont
Journal:  Inflamm Bowel Dis       Date:  2007-02       Impact factor: 5.325

Review 4.  Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.

Authors:  Dimitrios Damaskos; George Kolios
Journal:  Br J Clin Pharmacol       Date:  2008-02-12       Impact factor: 4.335

5.  Saccharomyces boulardii in maintenance treatment of Crohn's disease.

Authors:  M Guslandi; G Mezzi; M Sorghi; P A Testoni
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

6.  Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.

Authors:  C Prantera; M L Scribano; G Falasco; A Andreoli; C Luzi
Journal:  Gut       Date:  2002-09       Impact factor: 23.059
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.